Drugs / PvCS N+C+R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02083068 | Aug 2014 → Sep 2015 | Plasmodium vivax malaria | Malaria Vaccine and Drug Development Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PvCS N+C+R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02083068 ↗ |
| Modality | Vaccine | “Plasmodium vivax CS synthetic vaccine” PMID 35338131 ↗ Mar 2022 |